vs
Side-by-side financial comparison of 4D Molecular Therapeutics, Inc. (FDMT) and PAMT CORP (PAMT). Click either name above to swap in a different company.
PAMT CORP is the larger business by last-quarter revenue ($141.3M vs $85.1M, roughly 1.7× 4D Molecular Therapeutics, Inc.). 4D Molecular Therapeutics, Inc. runs the higher net margin — 22.8% vs -20.7%, a 43.5% gap on every dollar of revenue. On growth, 4D Molecular Therapeutics, Inc. posted the faster year-over-year revenue change (8508900.0% vs -15.1%). 4D Molecular Therapeutics, Inc. produced more free cash flow last quarter ($28.5M vs $-25.0M). Over the past eight quarters, 4D Molecular Therapeutics, Inc.'s revenue compounded faster (5412.6% CAGR vs -12.0%).
4D Molecular Therapeutics is a clinical-stage biotechnology company specializing in the research and development of targeted adeno-associated virus (AAV) gene therapies. Its core product candidates address unmet medical needs in ophthalmology, cardiology, and pulmonary disease segments, serving global patient populations with rare and common hard-to-treat conditions.
FDMT vs PAMT — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $85.1M | $141.3M |
| Net Profit | $19.4M | $-29.3M |
| Gross Margin | — | — |
| Operating Margin | 17.3% | -27.0% |
| Net Margin | 22.8% | -20.7% |
| Revenue YoY | 8508900.0% | -15.1% |
| Net Profit YoY | 139.1% | 7.4% |
| EPS (diluted) | $0.43 | $-1.38 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $85.1M | $141.3M | ||
| Q3 25 | $90.0K | $150.3M | ||
| Q2 25 | $15.0K | $151.1M | ||
| Q1 25 | $14.0K | $155.3M | ||
| Q4 24 | $1.0K | $166.5M | ||
| Q3 24 | $3.0K | $182.6M | ||
| Q2 24 | $5.0K | $182.9M | ||
| Q1 24 | $28.0K | $182.6M |
| Q4 25 | $19.4M | $-29.3M | ||
| Q3 25 | $-56.9M | $-5.6M | ||
| Q2 25 | $-54.7M | $-9.6M | ||
| Q1 25 | $-48.0M | $-8.1M | ||
| Q4 24 | — | $-31.6M | ||
| Q3 24 | $-43.8M | $2.4M | ||
| Q2 24 | $-35.0M | $-2.9M | ||
| Q1 24 | $-32.4M | $281.0K |
| Q4 25 | 17.3% | -27.0% | ||
| Q3 25 | -67983.3% | -3.8% | ||
| Q2 25 | -396373.3% | -7.3% | ||
| Q1 25 | -383007.1% | -5.9% | ||
| Q4 24 | — | -22.6% | ||
| Q3 24 | -1704400.0% | 1.3% | ||
| Q2 24 | -849120.0% | -0.4% | ||
| Q1 24 | -136200.0% | -0.4% |
| Q4 25 | 22.8% | -20.7% | ||
| Q3 25 | -63195.6% | -3.7% | ||
| Q2 25 | -364386.7% | -6.4% | ||
| Q1 25 | -342657.1% | -5.2% | ||
| Q4 24 | — | -19.0% | ||
| Q3 24 | -1461433.3% | 1.3% | ||
| Q2 24 | -699060.0% | -1.6% | ||
| Q1 24 | -115717.9% | 0.2% |
| Q4 25 | $0.43 | $-1.38 | ||
| Q3 25 | $-1.01 | $-0.27 | ||
| Q2 25 | $-0.98 | $-0.46 | ||
| Q1 25 | $-0.86 | $-0.37 | ||
| Q4 24 | — | $-1.44 | ||
| Q3 24 | $-0.79 | $0.11 | ||
| Q2 24 | $-0.63 | $-0.13 | ||
| Q1 24 | $-0.66 | $0.01 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $402.7M | $83.7M |
| Total DebtLower is stronger | — | $333.9M |
| Stockholders' EquityBook value | $505.7M | $210.5M |
| Total Assets | $566.7M | $697.9M |
| Debt / EquityLower = less leverage | — | 1.59× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $402.7M | $83.7M | ||
| Q3 25 | $305.1M | $115.6M | ||
| Q2 25 | $293.2M | $117.3M | ||
| Q1 25 | $321.4M | $102.7M | ||
| Q4 24 | $424.9M | $110.7M | ||
| Q3 24 | $501.9M | $92.3M | ||
| Q2 24 | $541.9M | $114.0M | ||
| Q1 24 | $525.9M | $125.8M |
| Q4 25 | — | $333.9M | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $325.6M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $505.7M | $210.5M | ||
| Q3 25 | $369.0M | $239.5M | ||
| Q2 25 | $420.9M | $244.9M | ||
| Q1 25 | $469.7M | $269.6M | ||
| Q4 24 | $510.6M | $277.5M | ||
| Q3 24 | $552.9M | $308.9M | ||
| Q2 24 | $588.3M | $306.7M | ||
| Q1 24 | $600.6M | $314.6M |
| Q4 25 | $566.7M | $697.9M | ||
| Q3 25 | $424.0M | $715.2M | ||
| Q2 25 | $473.6M | $707.9M | ||
| Q1 25 | $515.7M | $712.6M | ||
| Q4 24 | $560.4M | $741.7M | ||
| Q3 24 | $604.0M | $756.7M | ||
| Q2 24 | $620.1M | $733.5M | ||
| Q1 24 | $629.9M | $746.4M |
| Q4 25 | — | 1.59× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 1.17× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $28.6M | $-5.8M |
| Free Cash FlowOCF − Capex | $28.5M | $-25.0M |
| FCF MarginFCF / Revenue | 33.5% | -17.7% |
| Capex IntensityCapex / Revenue | 0.1% | 13.6% |
| Cash ConversionOCF / Net Profit | 1.47× | — |
| TTM Free Cash FlowTrailing 4 quarters | $-109.9M | $-23.4M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $28.6M | $-5.8M | ||
| Q3 25 | $-46.5M | $5.9M | ||
| Q2 25 | $-43.4M | $12.2M | ||
| Q1 25 | $-47.8M | $5.0M | ||
| Q4 24 | $-134.6M | $15.2M | ||
| Q3 24 | $-29.4M | $15.5M | ||
| Q2 24 | $-30.2M | $18.7M | ||
| Q1 24 | $-29.1M | $9.6M |
| Q4 25 | $28.5M | $-25.0M | ||
| Q3 25 | $-46.6M | $2.5M | ||
| Q2 25 | $-43.4M | $5.9M | ||
| Q1 25 | $-48.4M | $-6.8M | ||
| Q4 24 | $-138.4M | $-39.9M | ||
| Q3 24 | $-31.2M | $-33.6M | ||
| Q2 24 | $-30.6M | $4.1M | ||
| Q1 24 | $-29.8M | $-12.2M |
| Q4 25 | 33.5% | -17.7% | ||
| Q3 25 | -51765.6% | 1.7% | ||
| Q2 25 | -289620.0% | 3.9% | ||
| Q1 25 | -345635.7% | -4.4% | ||
| Q4 24 | -13837100.0% | -24.0% | ||
| Q3 24 | -1038966.7% | -18.4% | ||
| Q2 24 | -611840.0% | 2.2% | ||
| Q1 24 | -106421.4% | -6.7% |
| Q4 25 | 0.1% | 13.6% | ||
| Q3 25 | 101.1% | 2.3% | ||
| Q2 25 | 440.0% | 4.2% | ||
| Q1 25 | 4507.1% | 7.6% | ||
| Q4 24 | 378600.0% | 33.1% | ||
| Q3 24 | 59266.7% | 26.9% | ||
| Q2 24 | 6980.0% | 8.0% | ||
| Q1 24 | 2535.7% | 12.0% |
| Q4 25 | 1.47× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 6.44× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | 34.11× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
FDMT
Segment breakdown not available.
PAMT
| Freight Transportation Service | $123.1M | 87% |
| Fuel Surcharge | $18.2M | 13% |
